Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barre syndrome with preceding Campylobacter jejuni and other identified infections

Journal of Neuroimmunology

Volumn 81, Issue 1-2, 1998, Pages 116-126

  Hao, Qi ^a   Saida, Takahiko ^a   Kuroki, Shigekazu ^b   Nishimura, Masataka ^a   Nukina, Masafumi ^c   Obayashi, Hiroshi ^d   Saida, Kyoko ^a  

^a UTANO NATIONAL HOSPITAL   (Japan)

^b KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^c Public Health Research Institute of Kobe City   (Japan)

^d Kyoto Microbiological Institute   (Japan)

Author keywords

Anti glycolipid antibody; Campylobacter jejuni; Cytomegalovirus; Guillain Barre syndrome; Mycoplasma pneumoniae

Indexed keywords

GALACTOSYLCERAMIDE; GANGLIOSIDE ANTIBODY;

ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; BACTERIUM IDENTIFICATION; CAMPYLOBACTER JEJUNI; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FECES ANALYSIS; GRAM NEGATIVE INFECTION; GUILLAIN BARRE SYNDROME; HOST RESISTANCE; HUMAN; MAJOR CLINICAL STUDY; MYCOPLASMA PNEUMONIAE; PRIORITY JOURNAL; VIRUS DETECTION;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; ANTIGENS, BACTERIAL; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CHILD; CHILD, PRESCHOOL; COMORBIDITY; CYTOMEGALOVIRUS INFECTIONS; ENTERITIS; EUROPE; FECES; FEMALE; G(M1) GANGLIOSIDE; GALACTOSYLCERAMIDES; GANGLIOSIDES; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; JAPAN; MALE; MIDDLE AGED; MOLECULAR MIMICRY; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; POLYRADICULONEUROPATHY; UNITED STATES;

EID: 0031863348     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(97)00166-5     Document Type: Article

References (49)

1. Arnason, B.G.W., Soliven, B., 1993. Acute inflammatory demyelinating polyradiculneuropathies. In: Dyck, P.J., Tohomas, P.K., Griffin, J.W. (Eds.), Peripheral Neuropathy, 3rd ed. W.B. Saunders Company Press, Philadelphia, pp. 1437-1446.
2. Asbury A.K., Arnason B.G.W., Karp H.R., McFarlin D.E. Criteria for diagnosis of Guillain-Barré syndrome. Ann. Neurol. 3:1978;565-566.
3. Aspinall G.O., Fujimoto S., McDonald A.G., Pang H., Kurjanczyk L.A., Penner J.L. Lipopolysaccharides from Camylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure. Infect. Immun. 62:1994;2122-2125.
4. Blaser M.J., Wells J.G., Feldman R.A., Pollard R.A., Allen J.R. The Collaborative Diarrheal Disease Study Group: Campylobacter enteritis in United States: a multicenter study. Ann. Intern. Med. 98:1983;360-365.
5. Boucquey D., Sindic C.J.M., Lamy M., Delmee M. Clinical and serological studies in a series of 45 patients with Guillain-Barré syndrome. J. Neurol. Sci. 104:1991;56-63.
6. Dowling P.C., Cook S.D. Role of infection in Guillain-Barré syndrome: laboratory confirmation of herpes viruses in 41 case. Ann. Neurol. 9 (suppl.):1981;44-55.
7. Enders U., Karch H., Toyka K.V., Michels M., Zielasek J., Pette M., Heesemann J., Hartung H.P. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders. Ann. Neurol. 34:1993;136-144.
8. Gallo D., Walen K.H., Riggs J.L. Improved immunofluorescence antigens for detection of immunoglobulin M antibodies to Epstein-Barr viral capsid antigen and antibodies to Epstein-Barr virus nuclear antigen. J. Clin. Microbiol. 15:1982;243-248.
9. Goldschmidt B., Menonna J., Fortunato J., Dowling P., Dook S. Mycoplasma antibody in Guillain-Barré syndrome and other neurological disorders. Ann. Neurol. 7:1980;108-112.
10. Gregson N.A., Koblar S., Hughes R.A.C. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features Q. J. Med. 86:1993;111-117.
11. Gruenewald R., Ropper A.H., Lior H., Chann J., Lee R., Molinaro V.S. Serologic evidence of Campylobater jejuni/coli enteritis in patients with Guillain-Barré syndrome. Arch. Neurol. 48:1991;1080-1082.
12. Ho T.W., Mishu B., Li C.Y., Gao C.Y., Cornblath D.R., Griffin J.W., Asbury A.K., Blaser M.J., Mckhann G.M. Guillain-Barré syndrome in northern China; relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain. 118:1995;597-605.
13. Ilyas A.A., Mithen F.A., Chen Z.W., Cood S.D. Anti-GM1 IgA antibodies in Guillain-Barré syndrome. J. Neuroimmunol. 36:1992;69-76.
14. Jacobs B.C., Van Doorn P.A., Schmitz P.I.M., Tio-Gillen A.P., Herbrink P., Visser L.H., Hooijkaas H., van der Meche F.G.A. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome. Ann. Neurol. 40:1996;181-187.
15. Kaldor J., Speed B.R. Guillain-Barré syndrome and Campylobacter jejuni: a serological study. Br. Med. J. 288:1984;1867-1870.
16. Kaplan J.E., Schonberger L.B., Hurwitz E.S., Katona P. Guillain-Barré syndrome in the United States, 1978-1981: Additional observations from the national surveillance system. Neurology. 33:1983;633-637.
17. Kuroki S., Haruta T., Yoshioka M., Kobayashi Y., Nukina M., Nakanishi H. Guillain-Barré syndrome associated with Camylobacter infection. Pediatr. Infect. Dis. J. 10:1991;149-151.
18. Kuroki S., Saida T., Nukina M., Haruta T., Yoshioka M., Kobayashi Y., Nakanishi H. Campylobacter jejuni strains from patients with Guillain-Barré syndrome belong mostly to Penner serogroup 19 and contain β-N-acetylglucosamine residues. Ann. Neurol. 33:1993;243-247.
19. Kusunoki S., Chiba A., Hitoshi S., Takizawa H., Kanazawa I. Anti-Gal-C antibodies in autoimmune neropathies subsequent to Mycoplasma infection. Muscle Nerve. 18:1995;409-413.
20. MacDonald K.L., O'Leary M.J., Cohen M.L., Edmonds P., Brenner D.J., Janssen D., Davis J.P. Escherichia coli O157:H7: an emerging gastrointestinal pathogen: results of a one-year, prospective, population-based study. JAMA. 259:1998;3567-3570.
21. Matsusaki S., Katayama A., Kawaguchi N., Tanaka K. Incidence of Campylobacter jejuni/coli from healthy people. Kansenshogaku Zasshi. 57:1982;1-6. in Japanese.
22. McKhann G.M., Cornblath D.R., Griffin J.W., Ho T.W., Li C.Y., Jiang Z., Wu H.S., Zhaori G., Liu Y., Jou L.P., Liu T.C., Gao C.Y., Mao J.Y., Blaser M.J., Mishu B., Asbury A.K. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann. Neurol. 33:1993;333-342.
23. McMyne P.M.S., Penner J.L., Mathias R.G., Black W.A., Hennessy J.N. Serotyping of Campylobacter jejuni isolated from sporadic cases and outbreaks in British Columbia. J. Clin. Microbiol. 16:1982;281-285.
24. Mishu B., Ilyas A.A., Koski C.L., Vriesendorp F., Cook S.D., Mithen F.A., Blaser M.J. Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome. Ann. Intern. Med. 118:1993;947-953.
25. Nakanishi H., Nukina M., Murase M. Campylobacter enteritis: incidence and laboratory method. Food Sanitation Res. 31:1981;459-471. in Japanese.
26. Nishimura M., Saida T., Kuroki S., Kawabata T., Obayashi H., Saida K., Uchiyama T. Post-infection encephalitis with anti-galactocerebroside antibody subsequent to Mycoplasma pneumoniae infection. J. Neurol. Sci. 140:1996;91-95.
27. Nobile-Orazio E., Carpo M., Meucci N., Grassi M.P., Capitani E., Sciacco M., Mangoni A., Scarlato G. Guillain-Barré syndrome associated with high titers of anti-GM1 antibodies. J. Neurol. Sci. 109:1992;200-206.
28. Numazaki Y. Cytomegalovirus infection in Japan. Nihonrinsho. 35:1977;2738-2742. in Japanese.
29. Numazaki Y., Yano N., Morizuka T., Takai S., Ishida N. Primary infection with human cytomegalovirus: virus isolation from healthy infants and pregnant women. Am. J. Epidemiol. 91:1970;410-417.
30. Patton, C.M., Wachsmuth, I.K., 1992. Typing schemes: are current methods useful? In: Nachamkin, I., Blaser, M.J., Tompkins, L.S. (Eds.), Campylobacter jejuni: current status and future trends. American Society for Microbiology, Washington, DC, pp. 110-128.
31. Penner J.L., Hennessy J.N. Passive hemagglutination technique for serotyping Campylobacter fetus subsp. jejuni on the basis of soluble heat-stable antigens. J. Clin. Microbiol. 12:1980;732-737.
32. Rees J.H., Gregson N.A., Hughes R.A. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann. Neurol. 38:1995;809-816.
33. Rees J.H., Soudain S.E., Gregson N.A., Hughes R.A. Campylobacter jejuni infection and Guillain-Barré syndrome. N. Engl. J. Med. 333:1995;1374-1379.
34. Saida K., Saida T., Brown M.J., Silberberg D.H., Asbury A.K. Antiserum-mediated demyelination in vivo. A sequential study using intraneural injection of experimental allergic neuritis serum. Lab. Invest. 39:1978;449-462.
35. Saida T., Saida K., Silberberg D.H., Brown M.J. Experimental allergic neuritis induced by galactocerebroside. Ann. Neurol. 9 (suppl.):1981;87-101.
36. Simone L.L., Annuziata P., Maimone D., Liguori M., Leante R., Livrea P. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J. Neurol. Sci. 114:1993;49-55.
37. Skirrow M.B. A demographic survey of Campylobacter, Salmonella, and Shigella infections in England. Epidemiol. Infect. 99:1987;647-657.
38. Skirrow, M.B., Blaser, M.J., 1992. Clinical and epidemiologic considerations. In: Nachamkin, I., Blaser, M.J., Tompkins, L.S., (Eds.), Campylobacter jejuni: current status and future trends. American Society for Microbiology, Washington, DC, pp. 3-8.
39. van den Berg L.H., Marrink J., de Jager A.E.J., de Jong H.J., van Imhoff G.W., Latov N., Sadiq S.A. Anti-GM1 antibodies in patients with Guillain-Barré syndrome. J. Neurol. Neurosurg. Psychiatry. 55:1993;8-11.
40. the Dutch Guillain-Barré Study Group, Visser L.H., van der Meche F.G.A., Meulstee J., Rothbarth P.P.H., Jacobs B.C., Schmitz P.I.M., van Doorn P.A. Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Neurology. 47:1996;668-673.
41. von Wulffen H., Hartard C., Scharein E. Seroreactivity to Campylobacter jejuni and gangliosides in patients with Guillain-Barré syndrome. J. Infect. Dis. 170:1994;828-833.
42. Vriesendorp F.J., Mishu B., Blaser M.J., Koski C.L. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis. Ann. Neurol. 34:1993;130-135.
43. Walsh F.S., Cronin M., Koblar S., Doherty P., Winer J., Leon A., Hughes R.A.C. Association between glycoconjugate antibodies and Campylobacter infection in patients with Guillain-Barré syndrome. J. Neuroimmunol. 34:1991;43-51.
44. Winer J.B., Hughes R.A.C., Anderson M.J., Jones D.M., Kangro H., Watkins R.P.F. A prospective study of acute idiopathic neuropathy. II. Antecedent events. J. Neurol. Neurosurg. Psychiatry. 51:1988;613-618.
45. Yoshizaki E., Kamiki T., Sakazaki R., Tamura K. Studies on sporadic Campylobacter enteritis. Kansenshogaku Zasshi. 56:1982;1153-1159. in Japanese.
46. Yuan J.M., Saida T., Tang T., Xiao L., Hao Q. Preceding infective agents of Guillain-Barré syndrome in northern China. Muscle Nerve. 1 (Suppl.):1994;S234. Abs.
47. Yuki N., Yoshino H., Sato S., Miyatake T. Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology. 40:1990;1900-1902.
48. Yuki N., Taki T., Inagaki F., Kasama T., Takahashi M., Saito K., Hanada S., Miyatake T. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J. Exp. Med. 178:1993;1771-1775.
49. Zhao B., Yang Y., Huang H., Liu X. Acute polyradiculitis (Guillain-Barré syndrome): an epidemiological study of 156 cases observed in Beijing. Ann. Neurol. 9 (suppl.):1981;146-148.